Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
The use of organophosphorus pesticides results in toxicity risk to non-target organisms. Organophosphorus compounds share a common mode of action, exerting their toxic effects primarily via acetylcholinesterase (AChE) inhibition. Consequently, acetylcholine accumulates in the synaptic clefts of muscles and nerves, leading to overstimulation of cholinergic receptors. Acute cholinergic crisis immediately follows exposure to organophosphate and includes signs and symptoms resulting from hyperstimulation of central and peripheral muscarinic and nicotinic receptors. The current view of the treatment of organophosphate poisoning includes three strategies, i.e. the use of an anticholinergic drug (e.g., atropine), cholinesterase-reactivating agents (e.g., oximes) and anticonvulsant drugs (e.g., benzodiazepines). Oximes, as a part of antidotal therapy, ensure the recovery of phosphylated enzymes via a process denoted as reactivation of inhibited AChE. However, both experimental results and clinical findings have demonstrated that different oximes are not equally effective against poisonings caused by structurally different organophosphorus compounds. Therefore, antidotal characteristics of conventionally used oximes can be evaluated regarding how close the certain substance is to the theoretical concept of the universal oxime. Pralidoxime (PAM-2), trimedoxime (TMB-4), obidoxime (LüH-6), HI-6 and HLö-7 have all been demonstrated to be very effective in experimental poisonings with sarin and VX. TMB-4 and LüH-6 may reactivate tabun-inhibited AChE, whereas HI-6 possesses the ability to reactivate the soman-inhibited enzyme. An oxime HLö-7 seems to be an efficient reactivator of AChE inhibited by any of the four organophosphorus warfare agents. According to the available literature, the oximes LüH-6 and TMB-4, although relatively toxic, are the most potent to induce reactivation of AChE inhibited by the majority of organophosphorus pesticides. Since there are no reports of controlled clinical trials on the use of TMB-4 in human organophosphate pesticide poisoning, LüH-6 may be a better option.
Antonijevic
Biljana
B
Institute of Toxicological Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia. abiljana@pharmacy.bg.ac.yu
Stojiljkovic
Milos P
MP
D000110:Acetylcholinesterase / Q000737:chemistry; D000931:Antidotes; D002619:Chemical Warfare Agents / Q000633:toxicity; D002801:Cholinesterase Reactivators / Q000008:administration & dosage* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007306:Insecticides / Q000633:toxicity*; D009768:Obidoxime Chloride / Q000737:chemistry; D062025:Organophosphate Poisoning; D009946:Organothiophosphorus Compounds / Q000633:toxicity; D010091:Oximes / Q000008:administration & dosage* / Q000737:chemistry / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000737:chemistry; D012524:Sarin / Q000633:toxicity; D014289:Trimedoxime / Q000737:chemistry
D000110:Acetylcholinesterase; D000931:Antidotes; D002619:Chemical Warfare Agents; D002801:Cholinesterase Reactivators; D007306:Insecticides; D009768:Obidoxime Chloride; D009946:Organothiophosphorus Compounds; D010091:Oximes; D011220:Pralidoxime Compounds; D012524:Sarin; D014289:Trimedoxime; C009680:VX-agent; C028797:pralidoxime